Serum bilirubin levels are associated with poor functional outcomes in patients with acute ischemic stroke or transient ischemic attack
Authors:
Open Access
- 27 September 2021
- journal article
- research article
- Published by Springer Nature in BMC Neurology
- Vol. 21 (1) , 1-12
Abstract
Background: The prognostic value of serum bilirubin in stroke is controversial, since bilirubin has both neuroprotective and neurotoxic properties. We aimed to investigate the association between serum bilirubin, including total bilirubin (TBIL), direct bilirubin (DBIL) and indirect bilirubin (IBIL) and poor functional outcomes in patients with acute ischemic stroke (AIS) or transient ischemic attack (TIA). Methods: All patients with AIS or TIA were recruited from the Third China National Stroke Registry. The poor functional outcomes included modified Rankin Scale (mRS) score 2–6 and 3–6 at 3 months and 1 year. Multivariable logistic regression was used to investigate the associations of TBIL, DBIL, and IBIL with poor functional outcomes. Results: Among 11,121 enrolled patients, the median (interquartile range) of TBIL, DBIL, and IBIL was 13.30 (9.90–17.70), 3.80 (2.70–5.30), and 9.30 (6.70–12.80) µmol/L. After adjustment for conventional confounding factors, patients in the highest TBIL quartile had the highest proportion of mRS score 2–6 at 3 months (odds ratio [OR], 1.37; 95 % confidence interval [CI], 1.19–1.59) and 1 year (OR, 1.31; 95 % CI, 1.13–1.52), and mRS score 3–6 at 3 months (OR, 1.33; 95 % CI, 1.11–1.59) and 1 year (OR, 1.28; 95 % CI, 1.07–1.53), when compared to patients in the lowest TBIL quartile. Similar results were observed for DBIL and IBIL. We also found J-shaped associations between serum bilirubin levels and each outcome. Conclusions: Elevated levels of serum bilirubin were significantly associated with poor functional outcomes in patients with AIS or TIA at 3 months and 1 year.Keywords
Funding Information
- Beijing Municipal Administration of Hospitals Incubating Program (PX2020021)
- beijing excellent talents training program (2018000021469G234)
- National Natural Science Foundation of China (81870905, U20A20358)
- Beijing Municipal Science & Technology Commission (D171100003017002)
This publication has 30 references indexed in Scilit:
- Elevated bilirubin after acute ischemic stroke linked to the stroke severityInternational Journal of Developmental Neuroscience, 2013
- Long-Term Survival of Ischemic Cerebrovascular Disease in the Acute Inflammatory Stroke Study, a Hospital-Based Cohort Described by TOAST and ASCOCerebrovascular Diseases, 2013
- SERUM BILIRUBIN AND URIC ACID LEVELS AS THE BAD PROGNOSTIC FACTORS IN THE ISCHEMIC STROKEInternational Journal of Neuroscience, 2009
- Heme oxygenase-1 induction prevents neuronal damage triggered during mitochondrial inhibition: Role of CO and bilirubinThe International Journal of Biochemistry & Cell Biology, 2009
- Bilirubin and glutathione have complementary antioxidant and cytoprotective rolesProceedings of the National Academy of Sciences, 2009
- Serum Total Bilirubin Level, Prevalent Stroke, and Stroke Outcomes: NHANES 1999–2004The American Journal of Medicine, 2008
- Association of Serum Bilirubin with Ischemic Stroke OutcomesJournal of Stroke and Cerebrovascular Diseases, 2008
- Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and womenAtherosclerosis, 2006
- Outcome in patients with basilar artery occlusion treated conventionallyJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993